1. DDW: _Association between HBV Replication and Serum ALT Changes is
not Dependent on HBV Genotype and Mutants _
(http://www.natap.org/2009/DDW/DDW_06.htm) - (06/08/09)
2. DDW: _Regression of Fibrosis/Cirrhosis with Long-Term Entecavir
Therapy in Chronic Hepatitis B (CHB) Patients with Baseline Bridging Fibrosis
or Cirrhosis: Results from Studies ETV-022, -027 and -901 _
(http://www.natap.org/2009/DDW/DDW_05.htm) - (06/08/09)
3. DDW: _Long-Term Histological Improvement with Entecavir (ETV)
Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide
Development Programs _ (http://www.natap.org/2009/DDW/DDW_04.htm) -
(06/08/09)
4. DDW: _Risk and Predictors of HCC in People Less than 40 years of
Age: Update from the R.E.V.E.A.L.-HBV Study_
(http://www.natap.org/2009/DDW/DDW_03.htm) - (06/08/09)
5. DDW: _Entecavir (ETV) Therapy in Chronic Hepatitis B Patients
Previously Treated with Adefovir (ADV) with Incomplete Response On-Treatment or
Relapse Off-Treatment _ (http://www.natap.org/2009/DDW/DDW_02.htm) -
(06/08/09)
6. DDW: _Entecavir Maintains a High Genetic Barrier to HBV Resistance
Through 6 Years in Naïve Patients _
(http://www.natap.org/2009/DDW/DDW_01.htm) - (06/08/09)
Dema-@aol.com
